Vesicant Agents and Antivesicant Medical Countermeasures: Clinical Toxicology and Psychological Implications

REFERENCES

• Alexander, S. F. (1947). Medical report of the Bari Harbor mustard casualties. The Military Surgeon, 101, 1–17.
   PubMedGoogle Scholar
• Balali-Mood, M. (1986). First reports of delayed toxic effects of yperite poisoning in Iranian fighters. In B. Heyndricks (Ed.), Terrorism: Analysis and detection of explosives (pp. 489–495). Ghent, Belgium: Rijksuniversiteit.
   Google Scholar
• Balali-Mood, M. (1996). Delayed toxic effects of sulfur mustard in 1428 patients. In Proceedings of the Chemical Biological Medical Treatment Symposium: An exploration of present capabilities and future requirements (pp. 125–133). Spiez, Switzerland.
   Google Scholar
• Cappizzi, R. L., Smith, W. J., Field, R. J., & Papirmeister, B. (1973). A host-mediated assay for chemical mutagens using the L5178Y/Asn(-) murine leukemia. Mutation Research, 21, 6.
   Web of Science ®Google Scholar
• Carus, W. S. (1988). Chemical weapons in the Middle East (Res. Memo No. 9:1-15). Washington, DC: Washington Institute for Near East Policy, Policy Focus.
   Google Scholar
• Dixon, M., & Needham, D. M. (1946). Biochemical research on chemical warfare agents. Nature, 158, 512–518.
   Web of Science ®Google Scholar
• Easton, D. F., Peto, J., & Doll, R. (1988). Cancers of the respiratory tract in mustard gas workers. British Journal of Industrial Medicine, 45, 653–659.
   Google Scholar
• Eisenmenger, W., Drasch, G., Von Clarmann, M., Kretschmer, E., & Roider, G. (1991). Clinical and morphological findings on mustard gas [bis(2-chloroethyl)sulfide] poisoning. Journal of Forensic Sciences, 36, 1688–1698.
   PubMed Web of Science ®Google Scholar
• Gross, C. L., Meier, H. L., Papirmeister, B., Brinkley, F. B., & Johnson, J. B. (1985). Sulfur mustard lowers nicotinamide dinucleotide concentrations in human skin grafted to athymic nude mice. Toxicology & Applied Pharmacology, 81, 85–90.
   PubMed Web of Science ®Google Scholar
• Hay, A., & Robert, G. (1990). The use of poison gas against the Iraqi Kurds: Analysis of bomb fragments, soil, and wool samples [Letter to the editor]. Journal of the American Medical Association, 263, 1065–1066.
   PubMed Web of Science ®Google Scholar
• Heller, C. E. (1984). Chemical warfare in World War I: The American experience, 1917—1918 (Leavenworth Papers No. 10). Fort Leavenworth, KS: Combat Studies Institute, Command and General Staff College.
   Google Scholar
• Henlly, F. (1956). Mass intoxication due to explosion of shell containing dichloroethyl sulfide dating back to World War I. Annales de Medicine Legale, 36, 195–204.
   Google Scholar
• Hoppmann, R. A., Peden, J. G., & Ober, S. K. (1991). Central nervous system side effects of non-steroidal anti-inflammatory drugs. Archives of Internal Medicine, 151, 1309–1313.
   PubMed Web of Science ®Google Scholar
• Hu, H., Cook-Deegan, R., & Shurki, A. (1989). The use of chemical weapons: Mounting an investigation using survey epidemiology. Journal of the American Medical Association, 262, 640–651.
   PubMed Web of Science ®Google Scholar
• Kadar, T., Amir, A., Fishbeine, E., Chapman, S., Liani, H., Sahar, R., et al. (1996). The potential therapy of steroids against ocular lesions induced by sulfur mustard vapor in rabbits. In Proceedings of the 1996 Medical Defense Bioscience Review (pp. 845–852). Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense.
   Google Scholar
• Kaufmann, M., Kahaner, K., Peselow, E. D., & Gershon, S. (1982). Steroid psychoses: Case report and brief overview. Journal of Clinical Psychiatry, 43, 75–76.
   PubMed Web of Science ®Google Scholar
• Krueger, G. P., & Banderet, L. E. (Eds.). (1997). Effects of chemical protective clothing on military performance [Special issue]. Military Psychology, 9 (4).
   Web of Science ®Google Scholar
• Lohs, K. (1975). Delayed toxic effects of chemical warfare agents (SIPRI monograph). Stockholm, Sweden: Almqvist & Wilksell.
   Google Scholar
• Martens, M. E. (1994). Hexose monophosphate shunt activity in human epidermal keratinocytes exposed to sulfur mustard. In Proceedings of the Meeting of Research Study Group-3 on Prophylaxis and Therapy Against Chemical Agents (NATO Technical Proceedings AC/243(Panel 8)TP/9, pp. 6.1-6.4). Brussels, Belgium: NATO.
   Google Scholar
• Maumenee, A. E., & Scholz, R. O. (1948). The histopathology of the ocular lesions produced by sulfur and nitrogen mustards. Bulletin Johns Hopkins Hospital, 82, 121–147.
   PubMedGoogle Scholar
• Medical management of chemical casualties handbook. (3rd ed.) (1999). Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense, Chemical Casualty Care Office.
   Google Scholar
• Meier, H. L., Gross, C. L., & Papirmeister, B. (1987). 2,2'-dichlorodiethyl sulfide (sulfur mustard) decreases NAD+ levels in human leukocytes. Toxicology Letters, 39, 109–122.
   PubMed Web of Science ®Google Scholar
• Mol, M. A. E., Van de Ruit, A. M. B. C., & Kluivers, A. W. (1989). NAD+ levels and glucose uptake of cultured human epidermal cells exposed to sulfur mustard. Toxicology & Applied Pharmacology, 98, 159–165.
   PubMed Web of Science ®Google Scholar
• Momeni, A., Enshaeih, S., Meghdadi, M., & Amindjavaheri, M. (1992). Skin manifestations of mustard gas. Archives of Dermatology, 128, 775–780.
   PubMed Web of Science ®Google Scholar
• Moore, D. W., & Keeler, J. R. (1993). Mustard agent poisoning: Pathophysiology and nursing implications. Critical Care Nurse, 13, 62–68.
   PubMedGoogle Scholar
• Papirmeister, B., Feister, A. J., Robinson, S. I., & Ford, R. D. (1991). Medical defense against mustard gas: Toxic mechanisms and pharmacological implications. Boca Raton, FL: CRC Press.
   Google Scholar
• Papirmeister, B., Gross, C. L., Meier, H. L., Petrali, J. P., & Johnson, J. B. (1985). Molecular basis for mustard-induced vesication. Fundamental & Applied Toxicology, 5, S134–S149.
   PubMedGoogle Scholar
• Pechura, C. M., & Rall, D. P. (Eds.). (1993). Veterans at risk: The health effects of mustard gas and lewisite. Washington, DC: National Academy Press.
   Google Scholar
• Rozmiarek, J., Cappizzi, R. L., Papirmeister, B., Furman, W. H., & Smith, W. J. (1973). Mutagenic activity in somatic and germ cells following chronic inhalation of sulfur mustard. Mutation Research, 21, 13.
   Web of Science ®Google Scholar
• Schnurr, P. P., Green, B. L., & Friedman, M. J. (1996). Post-traumatic stress disorder among World War II mustard gas test participants. Military Medicine, 161, 131–136.
   PubMed Web of Science ®Google Scholar
• Schnyder, J., & Bagglionoi, M. (1980). Induction of plasminogen activator secretion in macrophages by electrochemical stimulation of the hexose monophosphate shunt by methylene blue. Proceedings of the National Academy of Science (USA), 77, 414–417.
   PubMed Web of Science ®Google Scholar
• Sidell, F. R., Urbanetti, J. S., Smith, W. J., & Hurst, C. G. (1997). Vesicants. In R. Zajtchuk & R. F. Bellamy (Eds.), Textbook of military medicine: Medical aspects of chemical and biological warfare (pp. 197–228). Washington, DC: Office of the Surgeon General.
   Google Scholar
• Smith, K. J., Hurst, C. G., Moeller, R. B., Skelton, H. G., & Sidell, F. R. (1995). Sulfur mustard: Its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. Journal of the American Academy of Dermatology, 32, 765–776.
   PubMed Web of Science ®Google Scholar
• Smith, W. J., & Dunn, M. A. (1991). Medical defense against blistering chemical warfare agents. Archives of Dermatology, 127, 1207–1213.
   PubMed Web of Science ®Google Scholar
• Smith, W. J., Babin, M. C., Kiser, R. C., & Casillas, R. P. (2000). Development of medical countermeasures to sulfur mustard vesication. In Proceedings of the 22nd Army Science Conference (pp. 314–318. Washington, DC: Assistant Secretary of the Army (Acquisition, Logistics & Technology).
   Google Scholar
• Solberg, Y., Alcalay, M., & Belkin, M. (1997). Ocular injury by mustard gas. Survey of Opthamology, 41, 461–466.
   PubMed Web of Science ®Google Scholar
• Stewart, M. J. (1918). Report on cases of poisoning by “mustard gas,” with special reference to the histological changes and to alterations in the lymphocyte count (Rep. No. 17). London: Chemical Warfare Medical Committee.
   Google Scholar
• Stokes, J. W., & Banderet, L. E. (1997). Psychological aspects of chemical defense and warfare. Military Psychology, 9, 395–415.
   Web of Science ®Google Scholar
• Thomsen, A. B., Eriksen, J., & Smit-Nielsen, K. (1998). Chronic neuropathic symptoms after exposure to mustard gas: A long-term investigation. Journal of the American Academy of Dermatology, 39, 187–190.
   PubMed Web of Science ®Google Scholar
• United Nations. (1984, March). Report of the specialists appointed by the Secretary-General to investigate allegations by the Islamic Republic of Iran concerning the use of chemical weapons (Rep. No. S/16513). New York: Author.
   Google Scholar
• United Nations. (1986, March). Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between Iran and Iraq (Rep. No. S/17911). New York: Author.
   Google Scholar
• United Nations. (1987, May). Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq (Rep. No. S/18852). New York: Author.
   Google Scholar
• Urbanetti, J. S. (1988). Battlefield chemical inhalation injury. In J. Loke (Ed.), Pathophysiology and treatment of inhalation injuries (pp. 281–348). New York: Marcel Dekker.
   Google Scholar
• Vedder, E. B. (1925). The medical aspects of chemical warfare (pp. 125–166). Baltimore: Williams & Wilkins.
   Google Scholar
• Warthin, A. S., & Weller, C. V. (1919). The medical aspects of mustard gas poisoning. St. Louis: Mosby.
   Google Scholar
• Warthin, A. S., Weller, C. V., & Herrmann, G. R. (1918). The ocular lesions produced by dichlorethylsulphide (“mustard gas”). Journal of Laboratory & Clinical Medicine, 4, 785–832.
   Google Scholar
• Watson, A. P., Jones, T. D., & Griffin, G. D. (1989). Sulfur mustard as a carcinogen: Application of relative potency analysis to the chemical warfare agents H, HD, and HT. Regulatory Toxicology & Pharmacology, 10, 1–25.
   PubMed Web of Science ®Google Scholar
• Willems, J. L. (1989). Clinical management of mustard gas casualties. Annales Medicinae Militaris Belgicae, 3 (Suppl.), 1–61.
   Google Scholar